Cipla signs pact with Teva Pharmaceuticals for selling drugs in South AfricaThe collaboration will focus on oncology, central nervous system, women's health, cardiovascular, ophthalmology and other speciality produc...
Cipla Medpro collaborates with Teva Pharma; stock gainsThe collaboration is a sales and distribution arrangement whereby Cipla Medpro will exclusively sell Teva’s broad pharmaceutical product po...
Cipla unit gets 345 million rand contract from South AfricaUnder the contract, which will run from July 2014 to April 2017, the company will supply drugs including Beclate 100, Becalate 200 and Asth...
CIMB retains ‘outperform’ on CiplaThe recovery of its India business due to strong growth in respiratory and anti-infectives is positive. The Medpro acquisition is a near-te...
Brokerages upgrade Cipla after strong Q1 resultsBrokerages have raised their EPS estimates and target price on the stock on the back of rupee depreciation and Medpro acquisition.
Cipla completes buyout of Cipla Medpro for Rs 2,707 croreCipla on Tuesday said it has completed the buyout process of South African pharma firm Cipla Medpro for an aggregate consideration of Rs 2,...
Expect completion of Cipla Medpro takeover by mid July: Cipla"The operative date of the scheme is expected to be July 15, 2013 and the shares of Medpro are expected to be delisted from the JSE Ltd.
Cipla receives nod from South Africa authorities to acquire Cipla MedproCipla Ltd today said it has received approval from South Africa and Botswana for the $ 512 million takeover offer to acquire Cipla Medpro
- Doubts over Cipla India's takeover bid of S African unit
Analysts had expected shareholders to support the 100% takeover offer, but are now doubtful after questioning the reasons for Cipla SA want...
Cipla Medpro shareholder wants Cipla India to hike offer: ReportCipla Medpro is a South African affiliate of Cipla. The companies enjoy a long-standing business relationship spanning two decades.
- Cipla completes the Medpro deal, buys 100% stake in the South African company
The total consideration payable by Cipla is approximately $ 512 million or ZAR 4.5 billion.
Cipla puts Medpro buyout on hold over valuation issuesCipla decides to put on hold its $220-million acquisition plan of the third-largest South African drugmaker Cipla Medpro due to valuation i...
- Cipla Medpro likely to push India's Cipla to raise bid
Cipla Ltd is to offer 8.55 rand per share for a 51 percent stake in Cipla Medpro. The Indian group supplies drugs to the Cape Town-based co...
Cipla-Medpro is a marketing tie-up, don’t own any stake in them: S Radhakrishnan, CiplaCipla is a major source of supply for Cipla Medpro South Africa. So that trend will continue and a significant portion of this order, says ...
Cipla set to buy 51% of S Africa's Cipla Medpro for about $220 millionCipla said on Wednesday it will buy 51% of Cipla Medpro for about $220 million, valuing the beleaguered South African company at about $440...
- Cipla looks to acquire 25% stake in South African co
Cipla said it could take a decision to buy stake of up to 25 per cent in South Africa-based, Cipla Medpro in next board meeting. Cipla Medp...
- Adcock's plan to buy Medpro hits Cipla hurdle
South African company Adcock Ingram's plans to buy Cipla Medpro, with whom Cipla has a 20-year drug-supply agreement, has run into trouble ...